Vertebral fracture risk reduction over two years with risedronate 35 mg once-a-week

被引：0
|
作者：
Watts, NB
Lindsay, R
Li, Z
Brown, J
机构：
[1] Univ Cincinnati, Bone Hlth & Osteoporosis Ctr, Cincinnati, OH USA
[2] Helen Hayes Hosp, Reg Bone Ctr, W Haverstraw, NY USA
[3] Procter & Gamble Pharmaceut, Cincinnati, OH USA
[4] CHUQ, Ctr Rech, Quebec City, PQ, Canada
来源：
OSTEOPOROSIS INTERNATIONAL | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P82
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] Two year vertebral fracture risk reduction with risedronate 35 mg once-a-week
    Watts, NB
    Lindsay, R
    Li, Z
    Kasibhatla, C
    Brown, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S36 - S36
  • [2] Once-a-week risedronate is effective in reducing vertebral fracture risk
    Brown, J
    Watts, WN
    Olszynski, W
    Adachi, JD
    [J]. JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1877 - 1877
  • [3] Efficacy of once-a-week risedronate in reducing vertebral fracture risk
    Watts, NB
    Li, Z
    Hoseyni, MS
    Seeman, E
    Lindsay, R
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S17 - S18
  • [4] Once-a-week (35 mg) risedronate is as effective as daily (5 mg)
    Lindsay, R
    Adachi, JD
    Emkey, RD
    Li, Z
    Balske, A
    Brown, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S16 - S16
  • [5] VERTEBRAL FRACTURE RISK REDUCTION WITH RISEDRONATE 150 MG ONCE-A-MONTH
    Watts, Nelson B.
    Klemes, Andrea B.
    Wagner, Leigh
    Brown, Jacques P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S211 - S211
  • [6] Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet
    M. R. McClung
    P. D. Miller
    J. P. Brown
    J. Zanchetta
    M. A. Bolognese
    C. L. Benhamou
    A. Balske
    D. E. Burgio
    J. Sarley
    L. K. McCullough
    R. R. Recker
    [J]. Osteoporosis International, 2012, 23 : 267 - 276
  • [7] Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet
    McClung, M. R.
    Miller, P. D.
    Brown, J. P.
    Zanchetta, J.
    Bolognese, M. A.
    Benhamou, C. L.
    Balske, A.
    Burgio, D. E.
    Sarley, J.
    McCullough, L. K.
    Recker, R. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) : 267 - 276
  • [8] EFFECT OF A DELAYED-RELEASE RISEDRONATE 35 MG ONCE-A-WEEK FORMULATION TAKEN WITH OR WITHOUT BREAKFAST ON BMD
    McClung, M. R.
    Zanchetta, J. R.
    Benhamou, C. L.
    Balske, A.
    Sarley, J.
    Recker, R. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 25 - 25
  • [9] Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate
    Watts, NB
    Lindsay, R
    Li, ZQ
    Kasibhatla, C
    Brown, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 (05) : 437 - 441
  • [10] Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate
    Nelson B. Watts
    Robert Lindsay
    Zhengqing Li
    Chandrasekhar Kasibhatla
    Jacques Brown
    [J]. Osteoporosis International, 2003, 14 : 437 - 441
12345